STUDY OF ANTI-BACTERIAL AND ANTI-INFLAMMATORY PROPERTIES OF INDONESIA’S FLORA BIODIVERSITY AS DRUG CANDIDATES FOR DIABETIC ULCER THROUGH IN SILICO AND IN VITRO APPROACH
Main Article Content
Abstract
This study is driven by the substantial increase in the number of diabetes mellitus patients, which is projected to triple by 2030 and the immense potential of Indonesia's extensive biodiversity. Diabetic ulcers represent one of the most common complications stemming from uncontrolled diabetes mellitus. Therefore, this research aims to determine the therapeutic potential of Indonesian biodiversity for diabetic ulcers, focusing on the anti-bacterial and anti-inflammatory properties of secondary metabolite derivatives, employing both in silico and in vitro approaches. Initially, the research employed an in silico approach, conducting molecular docking and molecular dynamics simulations on reference ligands obtained from the 6KVS receptor for Staphylococcus aureus bacteria and the 5KIR for the COX-2 protein. Molecular docking was performed for 18 secondary metabolite derivative test compounds using Autodock Vina, followed by molecular dynamics simulations. The results of the molecular dynamics simulations showed that flavanonols exhibited the highest stability among the test compounds, with an average root mean squared deviation of 0.139493 Å for anti-bacterial tests and 0.182499 Å for anti-inflammatory tests after 50 ns simulation. Based on the results of molecular dynamics simulations, in vitro anti-bacterial and anti-inflammatory testing was conducted using flavanonol compounds found in Ananas comosus plants. In the anti-bacterial test, the pineapple extract, at a 5% concentration, exhibited the largest inhibitory zone diameter, 3.53 mm. In the anti-inflammatory tests, the pineapple extract at an optimal concentration of 600 ppm showed the highest absorbance value for protein denaturation, measuring 0.11133 au.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
a). Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution-NonCommercial-ShareAlike 4.0 International that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b). Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c). Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
References
Al-Khayri JM, Sahana GR, Nagella P, Jo-seph BV, Alessa FM, Al-Mssallem MQ (2022) Flavonoids as potential anti-inflammatory molecules: a review.
Molecules 27(9):2901. doi: 10.3390/molecules27092901.
Benet LZ, Hosey CM, Ursu O, Oprea TI (2016) BDDCS, the Rule of 5 and dru-gability. Adv Drug Deliv Rev 101:89-98. doi: 10.1016/j.addr.2016.05.007.
Bolton L (2018) Managing patients with dia-betic foot ulcers. Wounds ;30(12):380-381.
Choy YB, Prausnitz MR (2011) The rule of five for non-oral routes of drug deliv-ery: ophthalmic, inhalation and trans-dermal. Pharm Res 28(5):943-8. doi: 10.1007/s11095-010-0292-6.
Cushnie TP, Lamb AJ (2005) Antimicrobial activity of flavonoids. Int J Antimicrob Agents 26(5):343-56. doi: 10.1016/j.ijantimicag.2005.09.002.
Dorresteijn JA, Kriegsman DM, Assendelft WJ, Valk GD (2014) Patient education for preventing diabetic foot ulceration. Cochrane Database Syst Rev 2014(12):CD001488. doi: 10.1002/14651858.CD001488.pub5.
Dunyach-Remy C, Ngba Essebe C, Sotto A, Lavigne JP (2016) Staphylococcus aureus toxins and diabetic foot ulcers: role in pathogenesis and interest in di-agnosis. Toxins 8(7):209. doi: 10.3390/toxins8070209.
Genco RJ, Borgnakke WS (2020) Diabetes as a potential risk for periodontitis: as-sociation studies. Periodontol 2000 83(1):40-45. doi: 10.1111/prd.12270. PMID: 32385881.
Giacomozzi C, Sartor CD, Telles R, Uccioli L, Sacco ICN (2018) Ulcer-risk classi-fication and plantar pressure distribu-tion in patients with diabetic polyneu-ropathy: exploring the factors that can lead to foot ulceration. Ann Ist Super Sanita 54(4):284-293. doi: 10.4415/ANN_18_04_04.
Ginwala R, Bhavsar R, Chigbu DI, Jain P, Khan ZK (2019) Potential role of fla-vonoids in treating chronic inflammato-ry diseases with a special focus on the anti-inflammatory activity of apigenin. Antioxidants 8(2):35. doi: 10.3390/antiox8020035.
Goh, T. C., Bajuri, M. Y., C. Nadarajah, S., Abdul Rashid, A. H., Baharuddin, S., & Zamri, K. S. (2020). Clinical and bac-teriological profile of diabetic foot
infections in a tertiary care. Journal of Foot and Ankle Research, 13(1). doi:10.1186/s13047-020-00406-y
Hatem, Mohamed Abdulhameed., Kamal, Dhafer M., Yusuf, Khalifa Abdulrah-man (2022). Diabetic foot limb threat-ening infections: Case series and management review. IJS Open 48():p 100568, November 2022. doi: 10.1016/j.ijso.2022.100568.
Hosseini M, Chen W, Xiao D, Wang C (2021) Computational molecular dock-ing and virtual screening revealed promising SARS-CoV-2 drugs. Precis Clin Med 4(1):1-16. doi: 10.1093/pcmedi/pbab001.
International Diabetes Federation (2021) IDF diabetes atlas, 10th edition. Brus-sels, Belgium: International Diabetes Federation.
Kar P, Kumar V, Vellingiri B, Sen A, Jaish-ee N, Anandraj A, Malhotra H, Bhattacharyya S, Mukhopadhyay S, Kinoshita M, Govindasamy V, Roy A, Naidoo D, Subramaniam MD (2022) Anisotine and amarogentin as promis-ing inhibitory candidates against SARS-CoV-2 proteins: a computation-al investigation. J Biomol Struct Dyn 40(10):4532-4542. doi: 10.1080/07391102.2020.1860133.
Kumar S, Pandey AK (2013) Chemistry and biological activities of flavonoids: an overview. ScientificWorldJournal 2013:162750. doi: 10.1155/2013/162750.
Levy N, Gillibrand W (2019) Management of diabetic foot ulcers in the communi-ty: an update. Br J Community Nurs 24(Sup3):S14-S19. doi: 10.12968/bjcn.2019.24.Sup3.S14.
Martínez Delgado M. M. (2018). Clinical case: complicated diabetic foot ul-cer. Revista espanola de sanidad pen-itenciaria, 20(3), 121–124.
Rupasinghe HPV (2020) Special issue "fla-vonoids and their disease prevention and treatment potential": recent ad-vances and future perspectives. Mole-cules 25(20):4746. doi: 10.3390/molecules25204746.
Santos LHS, Ferreira RS, Caffarena ER (2019) Integrating molecular docking and molecular dynamics simulations. Methods Mol Biol 2053:13-34. doi: 10.1007/978-1-4939-9752-7_2.
Shamsudin NF, Ahmed QU, Mahmood S, Ali Shah SA, Khatib A, Mukhtar S, Al-sharif MA, Parveen H, Zakaria ZA (2022) Antibacterial effects of flavo-noids and their structure-activity rela-tionship study: a comparative interpre-tation. Molecules 27(4):1149. doi: 10.3390/molecules27041149.
Silaban H (2021) The effect of various con-centrations of ethanol extract of the leaves of Paederia foetida L. on the growth of Escherichia coli bacteria. JDDT 11(6):61-7. doi: 10.22270/jddt.v11i6.5037 .
Souza PCT, Limongelli V, Wu S, Marrink SJ, Monticelli L (2021) Perspectives on high-throughput ligand/protein docking with Martini MD simulations. Front Mol Biosci 8:657222. doi: 10.3389/fmolb.2021.657222.
Terefe EM, Ghosh A (2022) Molecular docking, validation, dynamics simula-tions, and pharmacokinetic prediction of phytochemicals isolated from Cro-ton dichogamus against the HIV-1 re-verse transcriptase. Bioinform Biol In-sights 16:11779322221125605. doi: 10.1177/11779322221125605.
Ullah A, Munir S, Badshah SL, Khan N, Ghani L, Poulson BG, Emwas AH, Jaremko M (2020) Important flavo-noids and their role as a therapeutic agent. Molecules 25(22):5243. doi: 10.3390/molecules25225243.
Vezza T, Rodríguez-Nogales A, Algieri F, Utrilla MP, Rodriguez-Cabezas ME, Galvez J (2016) Flavonoids in inflam-matory bowel disease: a review. Nutri-ents 8(4):211. doi: 10.3390/nu8040211.
Wang W, Wang J (2018) Toll-like receptor 4 (TLR4)/Cyclooxygenase-2 (COX-2) regulates prostate cancer cell prolif-eration, migration, and invasion by NF-κB activation. Med Sci Monit 24:5588-5597. doi: 10.12659/MSM.906857.
Yu YQ, Yang X, Wu XF, Fan YB (2021) Enhancing permeation of drug mole-cules across the skin via delivery in nanocarriers: novel strategies for ef-fective transdermal applications. Front Bioeng Biotechnol 9:646554. doi: 10.3389/fbioe.2021.646554.